文献速递腹部MR

定量磁共振成像生物标志物鉴别炎性胰腺肿块与胰腺癌的系统评价与Meta分析

Quantitative MR imaging biomarkers for distinguishing inflammatory pancreatic mass and pancreatic cancer-a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2024-04-19

该系统评价与Meta分析纳入24项研究,评估定量MR成像生物标志物鉴别炎性胰腺肿块(IPM)与胰腺癌(PC)的诊断性能。ADC鉴别肿块型胰腺炎与PC的合并敏感度/特异度为0.80/0.85,鉴别自身免疫性胰腺炎与PC为0.82/0.84;上游主胰管最大径≤4 mm和≤5 mm的合并敏感度/特异度分别为0.86/0.74和0.97/0.52。定量MR参数可作为无创影像生物标志物帮助鉴别恶性胰腺肿瘤与炎性肿块,从而有助于避免不必要的手术。

要点

  • ADC值在肿块型胰腺炎中高于PC,在自身免疫性胰腺炎中低于PC,两者应分开考虑。
  • ADC鉴别肿块型胰腺炎与PC的合并敏感度/特异度为0.80/0.85。
  • 上游主胰管最大径≤4 mm鉴别IPM与PC的合并敏感度/特异度为0.86/0.74。

核心结论

  • 定量MR成像生物标志物有助于鉴别炎性胰腺肿块与胰腺癌;ADC值在肿块型胰腺炎与自身免疫性胰腺炎之间存在差异,未来研究应分别考虑。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Cochrane Library和Web of Science至2023年8月,纳入24项研究,采用QUADAS-2评估偏倚风险与适用性,使用DerSimonian-Laird法计算合并敏感度、特异度、阳性似然比、阴性似然比和诊断比值比,单因素Meta回归分析异质性潜在因素。

诊断标准与关键数值

  • ADC鉴别肿块型胰腺炎与PC的合并敏感度/特异度为0.80/0.85。
  • ADC鉴别自身免疫性胰腺炎与PC的合并敏感度/特异度为0.82/0.84。
  • 上游主胰管最大径≤4 mm鉴别IPM与PC的合并敏感度/特异度为0.86/0.74。
  • 上游主胰管最大径≤5 mm鉴别IPM与PC的合并敏感度/特异度为0.97/0.52。
  • 灌注分数鉴别IPM与PC的合并敏感度/特异度为0.82/0.68,肿块硬度值的合并敏感度/特异度为0.82/0.77。

临床应用与阅片要点

  • 定量MR参数可作为无创影像生物标志物用于鉴别恶性胰腺肿瘤与胰腺炎性肿块,从而有助于避免不必要的手术。
  • ADC值鉴别肿块型胰腺炎与胰腺癌时高于胰腺癌,鉴别自身免疫性胰腺炎与胰腺癌时低于胰腺癌,两者不宜合并考虑。
  • 上游主胰管最大径≤5 mm鉴别IPM与PC的敏感度较高(0.97)但特异度较低(0.52)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic performance of quantitative magnetic resonance (MR) imaging biomarkers in distinguishing between inflammatory pancreatic masses (IPM) and pancreatic cancer (PC).

METHODS: A literature search was conducted using PubMed, Embase, the Cochrane Library, and Web of Science through August 2023. Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) was used to evaluate the risk of bias and applicability of the studies. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were calculated using the DerSimonian-Laird method. Univariate meta-regression analysis was used to identify the potential factors of heterogeneity.

RESULTS: Twenty-four studies were included in this meta-analysis. The two main types of IPM, mass-forming pancreatitis (MFP) and autoimmune pancreatitis (AIP), differ in their apparent diffusion coefficient (ADC) values. Compared with PC, the ADC value was higher in MFP but lower in AIP. The pooled sensitivity/specificity of ADC were 0.80/0.85 for distinguishing MFP from PC and 0.82/0.84 for distinguishing AIP from PC. The pooled sensitivity/specificity for the maximal diameter of the upstream main pancreatic duct (dMPD) was 0.86/0.74, with a cutoff of dMPD ≤ 4 mm, and 0.97/0.52, with a cutoff of dMPD ≤ 5 mm. The pooled sensitivity/specificity for perfusion fraction (f) was 0.82/0.68, and 0.82/0.77 for mass stiffness values.

CONCLUSIONS: Quantitative MR imaging biomarkers are useful in distinguishing between IPM and PC. ADC values differ between MFP and AIP, and they should be separated for consideration in future studies.

CLINICAL RELEVANCE STATEMENT: Quantitative MR parameters could serve as non-invasive imaging biomarkers for differentiating malignant pancreatic neoplasms from inflammatory masses of the pancreas, and hence help to avoid unnecessary surgery.

KEY POINTS: • Several quantitative MR imaging biomarkers performed well in differential diagnosis between inflammatory pancreatic mass and pancreatic cancer. • The ADC value could discern pancreatic cancer from mass-forming pancreatitis or autoimmune pancreatitis, if the two inflammatory mass types are not combined. • The diameter of main pancreatic duct had the highest specificity for differentiating autoimmune pancreatitis from pancreatic cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wang ZH, Zhu L, Xue HD, et al. Quantitative MR imaging biomarkers for distinguishing inflammatory pancreatic mass and pancreatic cancer-a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 38639911. doi:10.1007/s00330-024-10720-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。